I am a clinician-scientist with no more than 25% effort devoted directly to patient care. My translational neuroscience laboratory investigates human stem cell-derived RGC transplantation as a potential treatment capable of restoring lost vision to patients with optic neuropathy. In addition, we are interested in optic neuropathy pathogenesis and neuroprotection. I also lead a clinical research program looking at the development of novel biomarker diagnostics for glaucoma, investigating the clinical role of remote tonometry in the management of glaucoma, and hopefully soon we will have some glaucoma neuroprotection clinical trials running at Wilmer.
